Company / AR per Share
NeoGenomics Laboratories, Inc. AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$1.24
FY2025
5-year range
$0.93 / $1.24
FY2021-FY2025
Trend
+4.6%
vs FY2024
Sector context
#102 of 136
Health Care
What the data says
NeoGenomics Laboratories, Inc.'s ar per share of $1.24 is lower than 75% of companies in the Health Care sector (FY2025). AR per Share has increased for 4 consecutive years, from $0.93 in FY2021 to $1.24 in FY2025.
Based on SEC 10-K filings.
1.24 in FY2025 with a 5-year CAGR of +5.4%.
Improved from $1.05 to $1.24 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +8.9%
- 5-Year CAGR
- +5.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 136This company $1.24 Sector average $12.05
▼
-89.7% below sector average
Key checks
Key Insights
- NeoGenomics Laboratories, Inc.'s ar per share has grown for 4 consecutive years.
- In FY2025, ar per share increased 4.6% year-over-year.
- Ranks #102 out of 136 companies in the Health Care sector.
- Lowest ar per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.24 | +4.6% |
| FY2024 | $1.19 | +13.7% |
| FY2023 | $1.05 | +8.5% |
| FY2022 | $0.96 | +3.1% |
| FY2021 | $0.93 | -2.2% |
| FY2020 | $0.96 | +5.1% |
| FY2019 | $0.91 | +8.3% |
| FY2018 | $0.84 | +9.2% |
| FY2017 | $0.77 | +5.0% |
| FY2016 | $0.73 | -9.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026